Clinical Trial Update: Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating everolimus for relapsed or metastatic endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED